BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14715126)

  • 1. Use of hormonal replacement therapy after treatment of breast cancer.
    Lea R; Bannister E; Case A; Levesque P; Miller D; Provencher D; Rosolovich V;
    J Obstet Gynaecol Can; 2004 Jan; 26(1):49-60; quiz 62-4. PubMed ID: 14715126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hormonal replacement therapy after treatment of breast cancer. Number 142, May 2004.
    SOGC
    Int J Gynaecol Obstet; 2005 Feb; 88(2):216-21. PubMed ID: 15779107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer, pregnancy, and breastfeeding.
    Helewa M; Lévesque P; Provencher D; Lea RH; Rosolowich V; Shapiro HM;
    J Obstet Gynaecol Can; 2002 Feb; 24(2):164-80; quiz 181-4. PubMed ID: 12196882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004.
    Society of Obstetricians and Gynaecologists of Canada
    Int J Gynaecol Obstet; 2005 Feb; 88(2):222-8. PubMed ID: 15779109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal delivery of breech presentation.
    Kotaska A; Menticoglou S; Gagnon R;
    J Obstet Gynaecol Can; 2009 Jun; 31(6):557-566. PubMed ID: 19646324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.
    Holmberg L; Anderson H;
    Lancet; 2004 Feb; 363(9407):453-5. PubMed ID: 14962527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.
    Pritchard KI; Khan H; Levine M;
    CMAJ; 2002 Apr; 166(8):1017-22. PubMed ID: 12002977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic therapy in preterm premature rupture of the membranes.
    Yudin MH; van Schalkwyk J; Eyk NV; ;
    J Obstet Gynaecol Can; 2009 Sep; 31(9):863-867. PubMed ID: 19941711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOGC clinical guidelines. Hysterectomy.
    Lefebvre G; Allaire C; Jeffrey J; Vilos G; Arneja J; Birch C; Fortier M;
    J Obstet Gynaecol Can; 2002 Jan; 24(1):37-61; quiz 74-6. PubMed ID: 12196887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
    Zárate A
    Gac Med Mex; 2002; 138(1):105-7. PubMed ID: 11885123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal replacement therapy after gynaecological cancer.
    Biglia N; Mariani L; Marenco D; Robba C; Peano E; Kubatzki F; Sismondi P
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):191-6. PubMed ID: 17068403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?
    Baxter N;
    CMAJ; 2001 Jun; 164(13):1837-46. PubMed ID: 11450279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of prenatally diagnosed structural congenital anomalies.
    Gagnon A;
    J Obstet Gynaecol Can; 2009 Sep; 31(9):875-881. PubMed ID: 19941713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.